Literature DB >> 10227165

Altered temperature induction sensitivity of the lambda pR/cI857 system for controlled gene E expression in Escherichia coli.

W Jechlinger1, M P Szostak, A Witte, W Lubitz.   

Abstract

Cell lysis of Gram-negative bacteria can be efficiently achieved by expression of the cloned lysis gene E of bacteriophage PhiX174. Gene E expression is tightly controlled by the rightward lambda pR promoter and the temperature-sensitive repressor cI857 on lysis plasmid pAW12. The resulting empty bacterial cell envelopes, called bacterial ghosts, are currently under investigation as candidate vaccines. Expression of gene E is stringently repressed at temperatures up to 30 degrees C, whereas gene E expression, and thus cell lysis, is induced at temperatures higher than 30 degrees C due to thermal inactivation of the cI857 repressor. As a consequence, the production of ghosts requires that bacteria have to be grown at 28 degrees C before the lysis process is induced. In order to reflect the growth temperature of pathogenic bacteria in vivo, it seemed favorable to extend the heat stability of the lambda pR promoter/cI857 repressor system, allowing pathogens to grow at 37 degrees C before induction of lysis. In this study we describe a mutation in the lambda pR promoter, which allows stringent repression of gene E expression at temperatures up to 36 degrees C, but still permits induction of cell lysis at 42 degrees C.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10227165     DOI: 10.1111/j.1574-6968.1999.tb13524.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  10 in total

Review 1.  The Bacterial Ghost platform system: production and applications.

Authors:  Timo Langemann; Verena Juliana Koller; Abbas Muhammad; Pavol Kudela; Ulrike Beate Mayr; Werner Lubitz
Journal:  Bioeng Bugs       Date:  2010 Sep-Oct

2.  Characterization of a novel inactivated Salmonella enterica serovar Enteritidis vaccine candidate generated using a modified cI857/λ PR/gene E expression system.

Authors:  Chetan V Jawale; Atul A Chaudhari; Byung Woo Jeon; Rahul M Nandre; John Hwa Lee
Journal:  Infect Immun       Date:  2012-01-30       Impact factor: 3.441

3.  The plasmid vectors, pBS2ndd and pBS3ndd, for versatile cloning with low background in Escherichia coli.

Authors:  Tiwa Rotchanapreeda; Wasinee Ngonsawan; Manadsaree Klomtun; Jamorn Somana
Journal:  World J Microbiol Biotechnol       Date:  2018-06-06       Impact factor: 3.312

4.  Protection against Shiga-Toxigenic Escherichia coli by Non-Genetically Modified Organism Receptor Mimic Bacterial Ghosts.

Authors:  Adrienne W Paton; Austen Y Chen; Hui Wang; Lauren J McAllister; Florian Höggerl; Ulrike Beate Mayr; Lucy K Shewell; Michael P Jennings; Renato Morona; Werner Lubitz; James C Paton
Journal:  Infect Immun       Date:  2015-06-22       Impact factor: 3.441

5.  Functional display of ice nucleation protein InaZ on the surface of bacterial ghosts.

Authors:  Johannes Kassmannhuber; Mascha Rauscher; Lea Schöner; Angela Witte; Werner Lubitz
Journal:  Bioengineered       Date:  2017-01-25       Impact factor: 3.269

6.  Decoupling Growth and Production by Removing the Origin of Replication from a Bacterial Chromosome.

Authors:  Marje Kasari; Villu Kasari; Mirjam Kärmas; Arvi Jõers
Journal:  ACS Synth Biol       Date:  2022-07-07       Impact factor: 5.249

7.  Generation of Helicobacter pylori ghosts by PhiX protein E-mediated inactivation and their evaluation as vaccine candidates.

Authors:  Klaus Panthel; Wolfgang Jechlinger; Alexander Matis; Manfred Rohde; Michael Szostak; Werner Lubitz; Rainer Haas
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

Review 8.  Harnessing the potential of bacterial ghost for the effective delivery of drugs and biotherapeutics.

Authors:  Aditya Ganeshpurkar; Ankit Ganeshpurkar; Vikas Pandey; Abhishek Agnihotri; Divya Bansal; Nazneen Dubey
Journal:  Int J Pharm Investig       Date:  2014-01

9.  A novel one-step expression and immobilization method for the production of biocatalytic preparations.

Authors:  Ilka Sührer; Timo Langemann; Werner Lubitz; Dirk Weuster-Botz; Kathrin Castiglione
Journal:  Microb Cell Fact       Date:  2015-11-14       Impact factor: 5.328

10.  Development of a site-directed integration plasmid for heterologous gene expression in Mycoplasma gallisepticum.

Authors:  Isolde Nieszner; Martin Vronka; Ivana Indikova; Michael P Szostak
Journal:  PLoS One       Date:  2013-11-20       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.